Depression and Anxiety Trial, Recruiting (NCT06631781)

Depression and Anxiety Trial, Recruiting NCT06631781 Sponsor: Hebrew University of Jerusalem Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT06631781 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have some symptoms of depression, measured by a standard questionnaire score of 5 or higher (PHQ-8)
Your memory and thinking abilities are within a healthy range, based on a standard cognitive test score of 20 or higher (MoCA)
You are able and willing to sign a consent form and agree to take part in the study
You feel comfortable using a tablet computer based on your own assessment of your tech skills
You have sufficient vision and hearing — with the help of glasses, hearing aids, or other assistive devices if needed — to use a tablet and take part in a small group of about 6 people
You can fluently read, speak, and understand either Hebrew or English

Who may not be able to join:

You have been diagnosed with a condition that affects brain function or causes it to decline over time, such as Mild Cognitive Impairment, dementia, or Parkinson's disease (based on what you report about yourself)
You have been diagnosed with certain mental health conditions other than depression or anxiety — specifically schizophrenia, bipolar disorder, or psychotic disorders (based on what you report about yourself)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06631781

Sponsor: Hebrew University of Jerusalem

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

More information: https://clinicaltrials.gov/study/NCT06631781

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have some symptoms of depression, measured by a standard questionnaire score of 5 or higher (PHQ-8)
Your memory and thinking abilities are within a healthy range, based on a standard cognitive test score of 20 or higher (MoCA)
You are able and willing to sign a consent form and agree to take part in the study
You feel comfortable using a tablet computer based on your own assessment of your tech skills
You have sufficient vision and hearing — with the help of glasses, hearing aids, or other assistive devices if needed — to use a tablet and take part in a small group of about 6 people
You can fluently read, speak, and understand either Hebrew or English

Who may not be able to join:

You have been diagnosed with a condition that affects brain function or causes it to decline over time, such as Mild Cognitive Impairment, dementia, or Parkinson's disease (based on what you report about yourself)
You have been diagnosed with certain mental health conditions other than depression or anxiety — specifically schizophrenia, bipolar disorder, or psychotic disorders (based on what you report about yourself)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hebrew University of Jerusalem

Registry

ClinicalTrials.gov

Start date

2 February 2024

Est. completion

1 December 2024

Where this trial is recruiting

🇮🇱 Israel

Primary endpoints

Adaptive Cognitive Evaluation (ACE) Battery; Canadian Occupational Performance Measure (COPM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov